Word: patents
(lookup in dictionary)
(lookup stats)
Dates: during 1960-1969
Sort By: most recent first
(reverse)
...That Woman Down There!" From 5 p.m. until 2 a.m.. Disk Jockey Kallinger alternates hot gospel platters, patent medicine commercials and high-decibel "evangelists," who pay station XERF $87.50 per quarter-hour. The preachers do not come personally to XERF; they tape their spiels in the U.S. and send them...
...made no difference what ailed a man, or his wife, or his horse. The nostrum peddlers had a sure cure for it-and generally the same cure. With no legal restrictions, the patent medicine men made limitless claims. One ointment boasted that it could cure "ague in the face, swelled breasts, sore nipples, bronchitis, sore throats, quinsy, croup, felons, ringworms, burns, scalds, shingles, erysipelas, salt rheum, piles, inflammation of the eyes and bowels, bruises, fresh cut wounds, bilious cholic, scrofulous and milk-leg sores, inflammatory rheumatism and gout." Such was the gilded age of the patent medicine in America...
...Women, by Erskine Caldwell. A collection of the best short stories of an author whose touch with humor and horror is superb, and who deserves better than his reputation as a drugstore patent-fiction merchant...
...wide variety of diseases. Until 1953, according to Government charges, Cyanamid's aureomycin and Pfizer's terramycin accounted for 92% of the broad-spectrum market. At that point, all three defendants, plus New York's Heyden Chemical Co. (now Heyden-Newport Chemical Corp.), applied for patent rights on tetracycline, a new antibiotic made with an aureomycin base...
...last week's indictment, "knew that tetracycline represented a threat to the continuation of their dominant positions and unreasonably high profits." To keep that threat in check, the indictment alleges, Cyanamid bought out Heyden's rights to the development and agreed to help Pfizer get the tetracycline patent. In return, charges the Justice Department. Pfizer licensed Cyanamid to produce the drug. Later, to avoid a court fight that might have nullified the patent, Pfizer and Cyanamid let Bristol-Myers...